Open the map

Bio-Rad LaboratoriesBIO

Diagnostics · NYSE · USA

$360.40
Down 2.0% todayClose

Up 21.4% this year and +19.8% since June 26, ahead of the life science sector at +10.7%. Bio-Rad Laboratories supplies 1 mapped company.

Market cap
$9.6B
This year
+21.4%
1 year
+24.1%
P/E
43.0
P/S
3.7
P/B
1.3

Price vs the life science sector

since Jun 26BIOLife science sector, equal weight
Bio-Rad Laboratories (BIO) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BIO: +19.8% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%Jun 26AugSepOct 8BIO +19.8%Sector +10.7% Bio-Rad Laboratories (BIO) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BIO: +19.8% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%Jun 26AugSepOct 8BIO+19.8%Sector+10.7%

Supply chain

1 customer
SUPPLIERS →→ CUSTOMERSNone mappedLabcorp (LH)LHLabcorp+0.7%BIOBio-Rad Laborat…

Customers 1

Open the full chain →

About Bio-Rad Laboratories

Clinical diagnostics laboratories buy one part of the range, blood typing among the uses; life science researchers buy the other, for work such as droplet digital PCR.

Theme exposure

DiagnosticsLife science toolsResearch equipment

Products

  • Clinical diagnostics
  • Life science research equipment
  • Digital PCR

Competitors

Risks

  • Cyclical research demand
  • Value tied to Sartorius stake

Same segment: Diagnostics

Tests, imaging and assays that support clinical decision-making. Segment 6 of 8 in the Medicine, pharma & life science value chain.

Abbott LaboratoriesABT−0.2%NateraNTRA−1.2%IDEXX LaboratoriesIDXX+1.3%LabcorpLH+0.7%Quest DiagnosticsDGX+1.7%HologicHOLX

Compare BIO

Side by side with the largest companies in the same segment.

BIO vs ABTBIO vs NTRABIO vs IDXXBIO vs LHBIO vs DGXBIO vs HOLX

See where Bio-Rad Laboratories sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →